Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. identifies new GLCT-1 inhibitors

June 27, 2022

SAGE Therapeutics describes new GABA-A receptor modulators

June 27, 2022

Anti-HER2 domain-specific antibody-drug radioconjugates show promise in models of breast cancer

June 27, 2022

Sumitomo Pharma divulges Chk1 inhibitors

June 27, 2022

Servier patents new MAT2A inhibitors

June 27, 2022

Novel murine model may shed light for future strategies for aggressive glioblastoma

June 27, 2022

Ginisortamab restores gremlin-1-ablated BMP signaling in CRC cell lines

June 27, 2022

Inhibitor harms leukemic stem cells while boosting normal ones

June 23, 2022

Apellis and Affilogic expand R&D collaboration to include Nanofitins targeting TfR

June 23, 2022

Mindset Pharma collaborates with CAMH on preclinical evaluation of MSP-1014

June 23, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...